Dallas doctor convicted of tampering with IV bags linked to co-worker’s death and other emergencies

2024-12-24 11:19:11 source: category:Markets

DALLAS (AP) — A Dallas anesthesiologist was convicted Friday for injecting a nerve-blocking agent and other drugs into bags of intravenous fluid at a surgical center where he worked, which led to the death of a co-worker and caused cardiac emergencies for several patients, federal prosecutors said.

A jury convicted Raynaldo Riviera Ortiz Jr., 60, of four counts of tampering with consumer products resulting in serious bodily injury, one count of tampering with a consumer product and five counts of intentional adulteration of a drug, prosecutors said. A sentencing date has not yet been set for Ortiz, who faces up to 190 years in prison.

“Dr. Ortiz cloaked himself in the white coat of a healer, but instead of curing pain, he inflicted it,” U.S. Attorney Leigha Simonton for the northern district of Texas said in a video statement.

Prosecutors said that evidence presented at trial showed that numerous patients at Surgicare North Dallas suffered cardiac emergencies during routine medical procedures performed by various doctors between May 2022 and August 2022. During that time, an anesthesiologist who had worked at the facility earlier that day died while treating herself for dehydration using an IV bag.

Ortiz was arrested in September 2022.

Evidence presented at trial showed that at the time of the emergencies, Ortiz was facing disciplinary action for an alleged medical mistake made in one of the surgeries, prosecutors said.

More:Markets

Recommend

Utah AD Mark Harlan fined $40,000 for ripping referees and the Big 12 after loss to BYU

This article has been updated to include comments from the Big 12.After Utah’s last-minute 22-21 los

Videos show Chicago police fired nearly 100 shots over 41 seconds during fatal traffic stop

CHICAGO (AP) — Plainclothes Chicago police officers fired nearly 100 gunshots over 41 seconds during

Report: LB Josh Allen agrees to 5-year, $150 million extension with Jaguars

Corrections and clarifications: An earlier version of this story included incorrect terms for Jaguar